Bradley Sacks

Director at ULURU

Mr. Sacks is an investor and advisor and has been the Managing Member of Centric Capital Ventures LLC, a private investment entity, since 2009. Centric Capital has a 50% ownership position in a company that has licensed the rights to Altrazeal® for distribution in South Africa.

From 2006 until 2009, Mr. Sacks was the Managing Director, Global Head of Technology, Media, and Telecom M&A, of Bank of America Securities.

During the past five years, Mr. Sacks has served on the board of directors of Gondwana International Networks (Pty) Limited (South Africa), Care Fertility Group Limited and numerous companies that are subsidiaries of General Healthcare Group, the largest private services provider in the UK.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ULURU

ULURU is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex™ Aggregate technology and OraDisc™ transmucosal delivery system.


Industries

Employees

11-50

Links